EFIM Clinical Research Grant

Submitted by Aneta on 4 March 2026 - 14:17

We are pleased to announce the launch of the EFIM Clinical Research Grants 2026 programme. 
The EFIM Clinical Research Grant 2026 aims to support innovative and collaborative clinical research projects in Internal Medicine, strengthening research capacity and fostering cooperation between EFIM Ordinary and Associate National Societies.
The grants are designed to encourage innovative research that advances patient care, promotes evidence-based practice, and strengthens the academic community within Internal Medicine.

Opinion/decision on a Paediatric investigation plan (PIP): Voydeya, danicopan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: EMA/PE/0000227558

Submitted by Anonymous (not verified) on 4 March 2026 - 13:28

Opinion/decision on a Paediatric investigation plan (PIP): Voydeya, danicopan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: EMA/PE/0000227558

Opinion/decision on a Paediatric investigation plan (PIP): Zeftera (previously Zevtera), ceftobiprole medocaril (sodium), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP

Submitted by Anonymous (not verified) on 4 March 2026 - 13:23

Opinion/decision on a Paediatric investigation plan (PIP): Zeftera (previously Zevtera), ceftobiprole medocaril (sodium), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: EMA/PE/0000227526

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: EMA/PE/0000227425

Submitted by Anonymous (not verified) on 4 March 2026 - 13:09

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Blood and lymphatic system disorders, PIP number: EMA/PE/0000227425

Opinion/decision on a Paediatric investigation plan (PIP): Symkevi, tezacaftor,ivacaftor, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/00

Submitted by Anonymous (not verified) on 4 March 2026 - 13:00

Opinion/decision on a Paediatric investigation plan (PIP): Symkevi, tezacaftor,ivacaftor, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000227394

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: EMA/PE/0000226957

Submitted by Anonymous (not verified) on 4 March 2026 - 12:56

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: EMA/PE/0000226957

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness